Newsletter
The Real Chemistry Podcast

The Real Chemistry Podcast

The Real Chemistry podcast connects the dots between our guests and the innovative work they do to show up and shape the future of healthcare.

Latest From Series

Addressing the Omicron Variant: Dr. Monica Gandhi, Professor of Medicine, UCSF

As we head into the holiday season, there are a lot of questions and concerns about the Omicron variant. Dr. Monica Gandhi, Professor of Medicine at UCSF, joins the show to unpack the nuances of Omicron and share why she's optimistic about where we are in the pandemic.
December 23, 2021

Applying Lessons Learned from COVID-19: Dr. Scott Gottlieb, Former Commissioner, FDA

The year's final episode is here, and we saved the best for last! Dr. Scott Gottlieb, former FDA Commissioner, chats with Jim Weiss, our Founder & Chairman, about lessons learned from COVID-19, how variants will impact our future (i.e., JP Morgan 2022), and how we can prepare for the next pandemic.
December 16, 2021

Coming Out as LGBTQIA+: Beth Weiss, Global Head of Facilities, Real Chemistry & Jim Weiss, Founder & CEO, Real Chemistry

It's a family affair on this week's episode of the show! Our Global Head of Facilities, Beth Weiss, and Jim Weiss, our Founder, and CEO, join the show to chat about Beth's coming out journey and the importance of living as your authentic self.
October 28, 2021

Defining Market Access & Value: Amy Grogg, PharmD, Market Access and Value-Based Pricing Industry Leader

Curious about the basics of market access and value? Amy Grogg, PharmD, one of our CEO Advisory Board Members, joins the #RealChem to unpack all things market access and value. Plus, she dives into her appreciation of Green Day.
October 14, 2021

Ending Cancer as We Know It: Sung Poblete, President & CEO, Stand Up To Cancer

If Sung Poblete had one wish, it would be to put her company out of business because cancer as we know it is no more. The President & CEO of Stand Up to Cancer joins the show to discuss the mission of making every cancer patient a long-term survivor and shares her admiration of Rufus Wainwright.
October 7, 2021

Creating Change & Transformation in Healthcare: Maimah Karmo, President & CEO, Tigerlily Foundation

This week's guest is a true changemaker and force for good in healthcare. Maimah Karmo, President & CEO of the Tigerlily Foundation joins the show to discuss how she's advocating and driving actionable solutions in our industry. Plus, she shares her love of Michael Jackson’s Thriller album.
September 2, 2021

Listen on your favorite player

New to Podcasts? It's easy to get started!

The Real Chemistry Podcast

The Real Chemistry podcast connects the dots between our guests and the innovative work they do to show up and shape the future of healthcare. Why? So, you, the listener, are encouraged to join us in our relentless pursuit to make the world a healthier place for all. Some may call it idealism. We call it Real Chemistry.
View All Episodes

Host

Aaron Strout

Aaron Strout

Aaron is the CMO of Real Chemistry (formerly W2O Group), a global health innovation company committed to making the world a healthier place for all. He is a seasoned, strategic marketer who grew up in digital. During his 25+ years in the industry, he has been a pioneer in mobile and location-based marketing. Throughout his career, he has focused on client success, building high-performance teams and profitable revenue growth. Prior to joining W2O, Aaron spent time as the CMO of Powered Inc. (now part of Sprinklr), VP of social media at online community provider, Mzinga, and as director of digital marketing at Fidelity Investments. Aaron is the co-author of Location Based Marketing for Dummies (Wiley) and current host of the award-winning The Real Chemistry Podcast (formerly What2Know) (iTunes) which features industry leaders talking about innovation and best practices.

You may also like

Subscribe to Health Podcast Network and never miss new Episodes!

Join Our Newsletter

Proudly supported by:

cover
Episode #123 – Is It Getting Worse to Be a Nurse? John and David tackle the shortage, while exploring the implications it can have for our healthcare system as a whole.